- Home
- RPTX vs SRV Comparison
RPTX vs SRV Comparison
Compare RPTX & SRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- SRV
- Stock Information
- Founded
- RPTX 2016
- SRV 2007
- Country
- RPTX Canada
- SRV United States
- Employees
- RPTX N/A
- SRV N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- SRV Finance Companies
- Sector
- RPTX Health Care
- SRV Finance
- Exchange
- RPTX Nasdaq
- SRV Nasdaq
- Market Cap
- RPTX 119.7M
- SRV 125.6M
- IPO Year
- RPTX 2020
- SRV N/A
- Fundamental
- Price
- RPTX $3.75
- SRV $45.95
- Analyst Decision
- RPTX Strong Buy
- SRV
- Analyst Count
- RPTX 3
- SRV 0
- Target Price
- RPTX $17.33
- SRV N/A
- AVG Volume (30 Days)
- RPTX 147.3K
- SRV 33.9K
- Earning Date
- RPTX 11-07-2024
- SRV 01-01-0001
- Dividend Yield
- RPTX N/A
- SRV 13.38%
- EPS Growth
- RPTX N/A
- SRV N/A
- EPS
- RPTX N/A
- SRV N/A
- Revenue
- RPTX $68,683,000.00
- SRV N/A
- Revenue This Year
- RPTX $16.85
- SRV N/A
- Revenue Next Year
- RPTX N/A
- SRV N/A
- P/E Ratio
- RPTX N/A
- SRV N/A
- Revenue Growth
- RPTX N/A
- SRV N/A
- 52 Week Low
- RPTX $2.71
- SRV $30.73
- 52 Week High
- RPTX $8.49
- SRV $44.30
- Technical
- Relative Strength Index (RSI)
- RPTX 68.01
- SRV 77.50
- Support Level
- RPTX $3.37
- SRV $44.29
- Resistance Level
- RPTX $3.72
- SRV $46.36
- Average True Range (ATR)
- RPTX 0.19
- SRV 0.58
- MACD
- RPTX 0.03
- SRV 0.22
- Stochastic Oscillator
- RPTX 85.60
- SRV 89.35
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.
About SRV NXG Cushing Midstream Energy Fund of Beneficial Interest
NXG Cushing Midstream Energy Fund is a non-diversified, closed-end management investment company with an investment objective of seeking a high after-tax total return from a combination of capital appreciation and current income. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in midstream energy investments.